Orchestra BioMed Holdings Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -18.2% | -13.2% | -12.4% | +4.1% | +1.1% | -22.5% | -27.5% | +144.7% | +9.6% | -12.4% | +14.9% | |
| – | -19.1% | -14.2% | -13.0% | +3.1% | +0.9% | -25.0% | -30.9% | +172.5% | +10.4% | -10.8% | +15.6% | |
| – | +60.2% | -23.7% | +1.7% | +8.0% | -13.1% | -17.6% | +2.2% | +124.1% | -17.4% | -18.2% | -27.8% | |
| – | -19.5% | -14.3% | -13.1% | +2.7% | -0.2% | -25.3% | -32.0% | +182.5% | +11.2% | -11.4% | +16.5% | |
| – | +15.1% | -32.3% | +19.4% | +43.8% | -20.0% | -3.3% | -6.7% | -37.3% | +82.7% | -11.6% | -39.3% | |
| – | +6.6% | -21.2% | -39.1% | +234.3% | -26.1% | -22.0% | +37.0% | +97.3% | -15.1% | -10.6% | -9.7% | |
| – | -26.0% | -6.4% | +11.1% | +3.0% | +48.5% | -2.4% | +0.8% | +43.6% | -15.7% | -3.5% | +73.6% | |
| – | -47.8% | -7.1% | +39.2% | +11.8% | -0.1% | -4.4% | +10.1% | +21.1% | -19.0% | -18.2% | -1.6% | |
| – | -93.7% | -28.4% | -24.7% | +12.9% | +39.2% | +7.3% | +8.8% | +8.4% | +7.9% | +4.5% | +2.9% | |
| – | -7.9% | +15.7% | +87.0% | -24.7% | +8.7% | +8.4% | -4.6% | +59.6% | -28.1% | +3.6% | -2.9% | |
| – | – | – | – | – | – | +0.3% | +0.3% | -1.3% | +0.5% | +0.5% | +143.1% | |
| – | -14.6% | -16.0% | -22.8% | +4.7% | -28.7% | -48.9% | -98.2% | +14,726.8% | +44.9% | -19.6% | -42.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.5% | +0.0% | +0.1% | +5.1% | +1.2% | +0.4% | +0.4% | +35.9% | -4.3% | +25.5% | +1.7% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.